Home » Posts tagged 'Schaeffer Center'

Tag Archives: Schaeffer Center

A New Line of Specialty Drugs: PCSK9 Inhibitors (Part 2)

This fall, a new line of specialty drugs will hit the market- PCSK9 inhibitors.  PCSK9 inhibitors are a new class of drugs used to lower LDL (bad) cholesterol levels through stifling a protein (PCSK9). The drug is injected once or twice a month and is (more…)

What’s a Fair Price? The Debate Over Value & Cost of Specialty Drugs (Part 1)

When Turing Pharmaceuticals raised the price of a drug that had been on the market for over 60 years from $13 to $750 a pill there was overwhelming public dismay.  For many, it highlighted the growing concern over prescription drug prices.   (more…)

Vaccine-Preventable Diseases in Adults are Costly

With National Immunization Awareness Month upon us, and the fall respiratory season just around the corner, vaccines are sure to make their way into headlines.  It’s easy to get distracted by the controversy and politicizing that (more…)

Students Engage in Health Policy Research for Schaeffer Center’s Summer Internship Program

The Schaeffer Center’s 2nd Annual Summer Internship Program draws to a close as the nine student interns, working with faculty mentors, presented the findings of their independent research projects. Student research ranged from an (more…)

Four Evidence-Based Strategies to Improve Medicare

Medicare has undoubtedly helped millions of seniors and disabled adults receive health coverage since being signed into law in 1965.  Today, Medicare covers 55 million beneficiaries across the US. In the coming decades though, Medicare (more…)

The Schaeffer Center’s Data Core Bring a Wealth of Experience, Expertise

At the heart of the Schaeffer Center’s Data Core are a group of five research programmers who support faculty, contribute to research projects, and help students get up to speed on research programming.

Patricia St. Clair, Data Core Director, started the current research programming group when she joined (more…)

Ending Suffering by Ending Persons

The standard reasoning supporting physician-assisted suicide begins with a patient that is near death and is in, or expects to soon be in, a health state worse-than-death. The patient, acting in her own self-interest, wishes to die to get (more…)

U.S. Funding for HIV Treatment Associated with Employment Gains in sub-Saharan Africa

By: Jeremy Barofsky, Neeraj Sood, Zachary Wagner

Since 2003, the President’s Emergency Plan for AIDS Relief (PEPFAR) has provided billions of US tax dollars to expand HIV treatment, care, and prevention programs, mostly in sub-Saharan Africa. According to the Institute of Medicine, PEPFAR’s $54 billion authorization from 2003-2013 constitutes the “largest global health initiative focused (more…)

Medicare’s Big Fat Problem, Fiscal and Otherwise

Co-Authors: Dana Goldman, Bryan Tysinger, and Alwyn Cassil

You can’t draw a straight line between growing Medicare spending and expanding American waistlines. But policymakers would be wise to keep both in mind as they ponder how to pay for the health care of 75-million-plus baby boomers who likely will live longer in worse health thanks to rising rates of chronic conditions, (more…)

Follow CESR on Facebook

Follow Schaeffer on Facebook